New York · 2025 Regular Session · Bill
A 11627: Relates to coverage for the treatment of ameloblastoma
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 11627 is a bill introduced in the New York House on July 29, 2026. According to its official title, it concerns: Relates to coverage for the treatment of ameloblastoma. Primary sponsor: Rules Committee. It lists 1 additional sponsor. Most recent recorded action (July 29, 2026): REFERRED TO INSURANCE.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Relates to medical and dental coverage for the treatment of ameloblastoma which shall include but is not limited to dental implants and implant-related services.
Sponsors
Sponsors by party (alphabetical): Republican/Conservative/Independence 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Rules Committee | Primary sponsor | Not applicable (committee) | — | — |
| Josh Jensen | Co-sponsor | Republican/Conservative/Independence | House | 134 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO INSURANCE